| 摘要 |
The invention relates to particular crystalline forms of 2-methyl-2-[4-(3 -methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-pheny l]-propionitrile, its hydrates and solvates, its salts and hydrates and solv ates of its salts, certain processes for their preparation, pharmaceutical c ompositions containing these crystalline forms, and their use in diagnostic methods or, preferably, for the therapeutic treatment of warm-blooded animal s, especially humans, and their use as an intermediate or for the preparatio n of pharmaceutical preparations for use in diagnostic methods or, preferabl y, for the therapeutic treatment of warm-blooded animals, especially humans.
|
